Gut 2001;48:206-211 ( February )

Article

The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor  in the pathogenesis of non-alcoholic steatohepatitis A J Wigg^a, I C Roberts-Thomson^a, R B Dymock^b, P J McCarthy^c, R H Grose^a, A G Cummins^a

^a Department of Gastroenterology, Queen Elizabeth Hospital, Adelaide, South Australia, Australia, ^b Department of Histopathology, Queen Elizabeth Hospital, Adelaide, South Australia, Australia, ^c Department of Biochemistry, Repatriation General Hospital, Adelaide, South Australia, Australia

Correspondence to: A J Wigg, Unit of Gastroenterology and Hepatology, Flinders Medical Centre, Bedford Park, 5042, South Australia, Australia. alan.wigg{at}flinders.edu.au

Accepted for publication 18 July 2000

BACKGROUNDSmall intestinal bacterial overgrowth may contribute to the development of non-alcoholic steatohepatitis, perhaps by increasing intestinal permeability and promoting the absorption of endotoxin or other enteric bacterial products.
AIMSTo investigate the prevalence of small intestinal bacterial overgrowth, increased intestinal permeability, elevated endotoxin, and tumour necrosis factor  (TNF-) levels in patients with non-alcoholic steatohepatitis and in control subjects.
PATIENTS AND METHODSTwenty two patients with non-alcoholic steatohepatitis and 23 control subjects were studied. Small intestinal bacterial overgrowth was assessed by a combined ¹⁴C-D-xylose and lactulose breath test. Intestinal permeability was assessed by a dual lactulose-rhamnose sugar test. Serum endotoxin levels were determined using the limulus amoebocyte lysate assay and TNF- levels using an ELISA.
RESULTSSmall intestinal bacterial overgrowth was present in 50% of patients with non-alcoholic steatosis and 22% of control subjects (p=0.048). Mean TNF- levels in non-alcoholic steatohepatitis patients and control subjects were 14.2 and 7.5 pg/ml, respectively (p=0.001). Intestinal permeability and serum endotoxin levels were similar in the two groups.
CONCLUSIONSPatients with non-alcoholic steatohepatitis have a higher prevalence of small intestinal bacterial overgrowth, as assessed by the ¹⁴C-D-xylose-lactulose breath test, and higher TNF- levels in comparison with control subjects. This is not accompanied by increased intestinal permeability or elevated endotoxin levels.


Keywords: non-alcoholic steatohepatitis; small intestinal bacterial overgrowth; intestinal permeability; endotoxin; tumour necrosis factor

---

© 2001 by Gut
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Is bacterial ash the flash that ignites NASH?

G C FARRELL
Gut 2001 48: 148-149. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Matthews, R. P., Lorent, K., Manoral-Mobias, R., Huang, Y., Gong, W., Murray, I. V. J., Blair, I. A., Pack, M. (2009). TNF{alpha}-dependent hepatic steatosis and liver degeneration caused by mutation of zebrafish s-adenosylhomocysteine hydrolase. Development 136: 865-875 [Abstract] [Full Text]  
• Stefan, N., Kantartzis, K., Haring, H.-U. (2008). Causes and Metabolic Consequences of Fatty Liver. Endocr. Rev. 29: 939-960 [Abstract] [Full Text]  
• Anderson, N., Borlak, J. (2008). Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis. Pharmacol. Rev. 60: 311-357 [Abstract] [Full Text]  
• Thuy, S., Ladurner, R., Volynets, V., Wagner, S., Strahl, S., Konigsrainer, A., Maier, K.-P., Bischoff, S. C., Bergheim, I. (2008). Nonalcoholic Fatty Liver Disease in Humans Is Associated with Increased Plasma Endotoxin and Plasminogen Activator Inhibitor 1 Concentrations and with Fructose Intake. J. Nutr. 138: 1452-1455 [Abstract] [Full Text]  
• (2007). Abstracts. Gut 56: a1-a145 [Full Text]  
• Tolman, K. G., Fonseca, V., Dalpiaz, A., Tan, M. H. (2007). Spectrum of Liver Disease in Type 2 Diabetes and Management of Patients With Diabetes and Liver Disease. Diabetes Care 30: 734-743 [Full Text]  
• Brun, P., Castagliuolo, I., Leo, V. D., Buda, A., Pinzani, M., Palu, G., Martines, D. (2007). Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 292: G518-G525 [Abstract] [Full Text]  
• Brun, P, Castagliuolo, I, Floreani, A R, Buda, A, Blasone, L, Palu, G, Martines, D (2006). Increased risk of NASH in patients carrying the C(-159)T polymorphism in the CD14 gene promoter region.. Gut 55: 1212-1212 [Full Text]  
• Hanje, A. J., Fortune, B., Song, M., Hill, D., McClain, C. (2006). The Use of Selected Nutrition Supplements and Complementary and Alternative Medicine in Liver Disease. Nutr Clin Pract 21: 255-272 [Abstract] [Full Text]  
• Rivera, C. A., Abrams, S. H., Tcharmtchi, M. H., Allman, M., Ziba, T. T., Finegold, M. J., Smith, C. W. (2006). Feeding a corn oil/sucrose-enriched diet enhances steatohepatitis in sedentary rats. Am. J. Physiol. Gastrointest. Liver Physiol. 290: G386-G393 [Abstract] [Full Text]  
• Adams, L. A., Angulo, P., Lindor, K. D. (2005). Nonalcoholic fatty liver disease. CMAJ 172: 899-905 [Abstract] [Full Text]  
• Medina, J., Fernandez-Salazar, L. I., Garcia-Buey, L., Moreno-Otero, R. (2004). Approach to the Pathogenesis and Treatment of Nonalcoholic Steatohepatitis. Diabetes Care 27: 2057-2066 [Abstract] [Full Text]  
• Sahai, A., Malladi, P., Melin-Aldana, H., Green, R. M., Whitington, P. F. (2004). Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model. Am. J. Physiol. Gastrointest. Liver Physiol. 287: G264-G273 [Abstract] [Full Text]  
• Evans, C D J, Oien, K A, MacSween, R N M, Mills, P R (2002). Non-alcoholic steatohepatitis: a common cause of progressive chronic liver injury?. J. Clin. Pathol. 55: 689-692 [Abstract] [Full Text]  
• Day, C P (2002). Non-alcoholic steatohepatitis (NASH): where are we now and where are we going?. Gut 50: 585-588 [Abstract] [Full Text]  
• FARRELL, G C (2001). Is bacterial ash the flash that ignites NASH?. Gut 48: 148-149 [Full Text]